CB1 receptors in the preoptic anterior hypothalamus regulate win 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia

被引:90
作者
Rawls, SM
Cabassa, J
Geller, EB
Adler, MW
机构
[1] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA
[2] Temple Univ, Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA
关键词
D O I
10.1124/jpet.301.3.963
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study investigated the effect of the selective cannabinoid agonist, WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one], on body temperature. WIN 55212-2 (1, 2.5, 5, and 10 mg/kg, i.m.) induced hypothermia in a dose-dependent manner. The peak hypothermia occurred 60 to 180 min postinjection. Body temperature was still suppressed 5 h after the injection of the highest dose of WIN 55212-2. The selective CB1 antagonist, SR141716A [N- (piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamidehydrochloride] (5 and 10 mg/kg, i.m.), blocked the WIN 55212-2-induced hypothermia, suggesting that CB1 receptor activation mediated the hypothermia. In contrast, the selective CB2 antagonist, SR144528[N-{(1S)-endo-1,3,3-trimethyl bicyclo heptan-2-yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide}] (5 mg/kg, i.m.), did not alter the WIN 55212-2-induced hypothermia. Neither SR141716A nor SR144528 alone altered body temperature. WIN 55212-2 (1-30 mug/mul) injected directly into the preoptic anterior hypothalamic nucleus (POAH) induced hypothermia in an immediate and dose-dependent fashion. The hypothermia produced by intra-POAH injection of WIN 55212-2 was brief, with body temperature returning to baseline 60 min postinjection. SR141716A (5 mg/kg, i.m.) abolished the hypothermia induced by intra-POAH injection of WIN 55212-2 (30 mug/mul), indicating that CB1 receptors in the POAH mediated the hypothermia. The present results confirm the idea that CB1 receptors mediate the hypothermic response to cannabinoid agonists. Moreover, the present data suggest that 1) the POAH is the central locus for thermoregulation, and 2) CB1 receptors within the POAH are the primary mediators of cannabinoid-induced hypothermia.
引用
收藏
页码:963 / 968
页数:6
相关论文
共 40 条
[1]   CANNABINOID PRECIPITATED WITHDRAWAL BY THE SELECTIVE CANNABINOID RECEPTOR ANTAGONIST, SR 141716A [J].
ACETO, MD ;
SCATES, SM ;
LOWE, JA ;
MARTIN, BR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 282 (1-3) :R1-R2
[2]  
BOULANT JA, 1981, FED PROC, V40, P2843
[3]   Control of pain initiation by endogenous cannabinoids [J].
Calignano, A ;
La Rana, G ;
Giuffrida, A ;
Piomelli, D .
NATURE, 1998, 394 (6690) :277-281
[4]   Behavioral effects of cannabinoid agents in animals [J].
Chaperon, F ;
Thiébot, MH .
CRITICAL REVIEWS IN NEUROBIOLOGY, 1999, 13 (03) :243-281
[5]  
Compton DR, 1996, J PHARMACOL EXP THER, V277, P586
[6]  
COMPTON DR, 1992, J PHARMACOL EXP THER, V263, P1118
[7]   THE MECHANISM OF ACTION OF DELTA-9-TETRAHYDROCANNABINOL ON BODY-TEMPERATURE IN MICE [J].
DAVIES, JA ;
GRAHAM, JDP .
PSYCHOPHARMACOLOGY, 1980, 69 (03) :299-305
[8]  
DEVANE WA, 1988, MOL PHARMACOL, V34, P605
[9]   HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5 [J].
Dragic, T ;
Litwin, V ;
Allaway, GP ;
Martin, SR ;
Huang, YX ;
Nagashima, KA ;
Cayanan, C ;
Maddon, PJ ;
Koup, RA ;
Moore, JP ;
Paxton, WA .
NATURE, 1996, 381 (6584) :667-673
[10]  
FAN F, 1994, J PHARMACOL EXP THER, V271, P1383